EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pre-hospital admission of heparin in patients with suspected non-ST segment elevation acute coronary syndrome

Jonas Sundermeyer, Alina Schock, Caroline Kellner, Paul M Haller, Jonas Lehmacher, Niklas Thießen, Betül Toprak, Lea Scharlemann, Raphael Twerenbold, Nils Arne Sörensen, Peter Clemmensen, Johannes T Neumann

Clinical Research in Cardiology · 2025

DOI: 10.1007/s00392-024-02507-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Research in Cardiology, 2025. Verfasst von Jonas Sundermeyer und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Heart and Vascular Center Hamburg, Martinistr. 52, 20251, Hamburg, Germany. Hauptthemen laut MEDLINE: Heparin, Acute Coronary Syndrome, Anticoagulants, Emergency Medical Services. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Hamburg-Eppendorf (UKE).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Evidence supporting pre-hospital heparin administration in patients with suspected non-ST segment elevation acute coronary syndrome (NSTE-ACS) is lacking. We aim to evaluate if pre-hospital heparin administration by emergency medical service improves clinical outcome in patients with suspected NSTE-ACS.

Methods

Patients with suspected myocardial infarction (MI) presenting to the emergency department were prospectively enrolled from 2013 to 2021, excluding those with ST segment elevation MI. Patients with and without prehospital heparin administration were compared using propensity score matching. To assess the association between pre-hospital heparin loading, 30-day and 1-year mortality, Kaplan–Meier estimations and Cox regression models were used.

Results

Among 1,234 patients, median age was 69 years, 755 (61.2%) were male, 867 (70.5%) with known hypertension, 177 (14.4%) had diabetes, 280 (23.1%) were current smokers, and 444 (36.0%) had a history of CAD. Compared to patients without pre-hospital heparin administration, heparin pre-treated patients were more often active smokers (26.5% vs. 20.8%). After propensity matching, 475 patients with vs. without pre-hospital heparin administration were compared, with no significant difference in 30-day mortality (no-heparin 1.3% vs. heparin 0.4%) and 1-year mortality (no-heparin 7.2% vs. heparin 5.5%, adjusted HR 0.98, CI 0.95–1.01, p = 0.22). Bleeding events occurred at a low frequency (< 2%) and did not differ between groups.

Conclusions

In this study, pre-hospital heparin administration was not associated with improved clinical outcome in patients with suspected NSTE-ACS. These findings question pre-hospital heparin therapy in this patient population and might potentially warrant a more restricted utilization pending in-hospital risk assessment. Graphical abstract Pre-hospital admission of heparin in patients with suspected non-ST segment elevation acute coronary syndrome. ACS acute coronary syndrome, CI confidence interval, HR hazard ratio, NSTE non-ST segment elevation, STEMI ST-elevation myocardial infarction, UFH unfractionated heparin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HeparinAcute Coronary SyndromeAnticoagulantsEmergency Medical ServicesNon-ST Elevated Myocardial InfarctionHumansMaleFemaleAgedProspective StudiesMiddle AgedPropensity ScoreFollow-Up StudiesEmergency Service, Hospital

Stichwörter der Autor:innen

Acute coronary syndromeHeparinNSTE-ACSPre-hospital

Substanzen

HeparinAnticoagulants

Autor:innen und Institutionen

  • Department of Cardiology, University Heart and Vascular Center Hamburg, Martinistr. 52, 20251, Hamburg, Germany.
  • German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Hamburg, Germany.
  • Center for Population Health Innovation (POINT), Hamburg, Germany.
  • Department of Cardiology, University Heart and Vascular Center Hamburg, Martinistr. 52, 20251, Hamburg, Germany. j.neumann@uke.de.
  • German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Hamburg, Germany. j.neumann@uke.de.
  • Center for Population Health Innovation (POINT), Hamburg, Germany. j.neumann@uke.de.

Förderung

  • Universitätsklinikum Hamburg-Eppendorf (UKE)

Zitieren

APA

Sundermeyer, J., Schock, A., Kellner, C., Haller, P. M., Lehmacher, J., Thießen, N., Toprak, B., Scharlemann, L., Twerenbold, R., Sörensen, N. A., Clemmensen, P., & Neumann, J. T. (2025). Pre-hospital admission of heparin in patients with suspected non-ST segment elevation acute coronary syndrome. Clinical Research in Cardiology. https://doi.org/10.1007/s00392-024-02507-1

Vancouver

Sundermeyer J, Schock A, Kellner C, Haller PM, Lehmacher J, Thießen N, et al. Pre-hospital admission of heparin in patients with suspected non-ST segment elevation acute coronary syndrome. Clinical Research in Cardiology. 2025. doi:10.1007/s00392-024-02507-1

BibTeX
@article{Sundermeyer2025,
  author = {Sundermeyer, Jonas and Schock, Alina and Kellner, Caroline and Haller, Paul M and Lehmacher, Jonas and Thießen, Niklas and Toprak, Betül and Scharlemann, Lea and Twerenbold, Raphael and Sörensen, Nils Arne and Clemmensen, Peter and Neumann, Johannes T},
  title = {Pre-hospital admission of heparin in patients with suspected non-ST segment elevation acute coronary syndrome},
  journal = {Clinical Research in Cardiology},
  year = {2025},
  doi = {10.1007/s00392-024-02507-1}
}
Kostenlos starten →